Endoscopic Treatment of Obesity and Nutritional Aspects of Bariatric Endoscopy

Jan Král, Evžen Machytka, Veronika Horká, Jana Selucká, Filip Doleček, Julius Špičák, Viktorie Kovářová, Martin Haluzík, Marek Bužga, Jan Král, Evžen Machytka, Veronika Horká, Jana Selucká, Filip Doleček, Julius Špičák, Viktorie Kovářová, Martin Haluzík, Marek Bužga

Abstract

Obesity is a significant problem worldwide. Several serious diseases that decrease patient quality of life and increase mortality (high blood pressure, dyslipidaemia, type 2 diabetes etc.) are associated with obesity. Obesity treatment is a multidisciplinary and complex process that requires maximum patient compliance. Change of lifestyle is fundamental in the treatment of obesity. While pharmacotherapeutic options are available, their efficacy is limited. Surgical treatment though highly effective, carries the risk of complications and is thus indicated mostly in advanced stages of obesity. Endoscopic treatments of obesity are less invasive than surgical options, and are associated with fewer complications and nutritional deficits. Currently, there is a large spectrum of endoscopic methods based on the principles of gastric volume reduction, size restriction and gastric or small bowel bypass being explored with only few available in routine practice. The aim of this publication is to present an up-to-date summary of available endoscopic methods for the treatment of obesity focusing on their efficacy, safety and nutritional aspects.

Keywords: deficience; endoscopic bariatric and metabolic treatments (EBMTs); nutrition; obesity; weight loss.

Conflict of interest statement

The authors declare no conflict of interest.

Figures

Figure 1
Figure 1
Overview of endoscopic bariatric procedures: (A) intragastric balloon placement, (B) endoscopic sleeve gastroplasty, (C) duodenojejunal bypass, (D) TransPyloris Shuttle, (E) electrical stimulation, (F) SatiSphere, (G) aspiration therapy, (H) Primary Obesity Surgery Endoluminal (POSE).

References

    1. Yumuk V., Tsigos C., Fried M., Schindler K., Busetto L., Micic D., Toplak H., Obesity Management Task Force of the European Association for the Study of Obesity European Guidelines for Obesity Management in Adults. Obes. Facts. 2015;8:402–424. doi: 10.1159/000442721.
    1. WHO Organization Obesity and Overweight. [(accessed on 20 November 2021)]. Available online: .
    1. Overweight and Obesity—BMI Statistics. [(accessed on 20 November 2021)]. Available online: .
    1. Adult Obesity Facts. [(accessed on 11 October 2021)]; Available online: .
    1. Bluher M. Obesity: Global epidemiology and pathogenesis. Nat. Rev. Endocrinol. 2019;15:288–298. doi: 10.1038/s41574-019-0176-8.
    1. Heymsfield S.B., Wadden T.A. Mechanisms, pathophysiology, and management of obesity. N. Engl. J. Med. 2017;376:254–266. doi: 10.1056/NEJMra1514009.
    1. Cusi K. Role of obesity and lipotoxicity in the development of nonalcoholic steatohepatitis: Pathophysiology and clinical implications. Gastroenterology. 2012;142:711–725.e6. doi: 10.1053/j.gastro.2012.02.003.
    1. Yanovski S.Z., Yanovski J.A. Obesity. N. Engl. J. Med. 2002;346:591–602. doi: 10.1056/NEJMra012586.
    1. Sacks D., Baxter B., Campbell B.C.V., Carpenter J.S., Cognard C., Dippel D., Eesa M., Fischer U., Hausegger K., Hirsch J.A., et al. Multisociety Consensus Quality Improvement Revised Consensus Statement for Endovascular Therapy of Acute Ischemic Stroke. Int. J. Stroke. 2018;13:612–632. doi: 10.1016/j.jvir.2017.11.026.
    1. Pilitsi E., Farr O.M., Polyzos S.A., Perakakis N., Nolen-Doerr E., Papathanasiou A.E., Mantzoros C.S. Pharmacotherapy of obesity: Available medications and drugs under investigation. Metab. Clin. Exp. 2019;92:170–192. doi: 10.1016/j.metabol.2018.10.010.
    1. Eren-Yazicioglu C.Y., Yigit A., Dogruoz R.E., Yapici-Eser H. Can GLP-1 be a target for reward system related disorders? A Qualitative synthesis and systematic review analysis of studies on palatable food, drugs of abuse, and alcohol. Front. Behav. Neurosci. 2020;14:614884. doi: 10.3389/fnbeh.2020.614884.
    1. Eldar S., Heneghan H.M., Brethauer S.A., Schauer P.R. Bariatric surgery for treatment of obesity. Int. J. Obes. 2011;35:S16–S21. doi: 10.1038/ijo.2011.142.
    1. Smith B.R., Schauer P., Nguyen N.T. Surgical approaches to the treatment of obesity: Bariatric surgery. Med. Clin. North Am. 2011;95:1009–1030. doi: 10.1016/j.mcna.2011.06.010.
    1. Knowler W.C., Barrett-Connor E., Fowler S.E., Hamman R.F., Lachin J.M., Walker E.A., Nathan D.M. Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. N. Engl. J. Med. 2002;346:393–403.
    1. Jung S.H., Yoon J.H., Choi H.S., Nam S.J., Kim K.O., Kim D.H., Kim J.W., Sohn W., Hyun Y.S., Park C.H., et al. Obesity, Comparative efficacy of bariatric endoscopic procedures in the treatment of morbid obesity: A systematic review and network meta-analysis. Endoscopy. 2020;52:940–954. doi: 10.1055/a-1149-1862.
    1. Mechanick J.I., Apovian C., Brethauer S., Garvey W.T., Joffe A.M., Kim J., Kushner R.F., Lindquist R., Pessah-Pollack R., Seger J., et al. Clinical practice guidelines for the perioperative nutrition, metabolic, and nonsurgical support of patients undergoing bariatric procedures—2019 update: Cosponsored by American Association of Clinical Endocrinologists/American College of Endocrinology, the Obesity Society, American Society for Metabolic & Bariatric Surgery, Obesity Medicine Association, and American Society of Anesthesiologists—Executive summary. Endocr. Pract. 2019;25:1346–1359.
    1. Di Lorenzo N., Antoniou S.A., Batterham R.L., Busetto L., Godoroja D., Iossa A., Carrano F.M., Agresta F., Alarçon I., Azran C., et al. Clinical practice guidelines of the European Association for Endoscopic Surgery (EAES) on bariatric surgery: Update 2020 endorsed by IFSO-EC, EASO and ESPCOP. Surg. Endosc. 2020;34:2332–2358. doi: 10.1007/s00464-020-07555-y.
    1. McCarty T.R., Thompson C.C. The current state of bariatric endoscopy. Dig. Endosc. 2021;33:321–334. doi: 10.1111/den.13698.
    1. Tawadros A., Makar M., Kahaleh M., Sarkar A. Overview of bariatric and metabolic endoscopy interventions. Ther. Adv. Gastrointest. Endosc. 2020;13:2631774520935239. doi: 10.1177/2631774520935239.
    1. Sullivan S., Edmundowicz S.A., Thompson C.C. Endoscopic bariatric and metabolic therapies: New and emerging technologies. Gastroenterology. 2017;152:1791–1801. doi: 10.1053/j.gastro.2017.01.044.
    1. Rubino F., R′Bibo S.L., del Genio F., Mazumdar M., McGraw T.E. Metabolic surgery: The role of the gastrointestinal tract in diabetes mellitus. Nat. Rev. Endocrinol. 2010;6:102–109. doi: 10.1038/nrendo.2009.268.
    1. Hadefi A., Huberty V., Lemmers A., Arvanitakis M., Maggs D., Costamagna G., Devière J. Endoscopic duodenal mucosal resurfacing for the treatment of type 2 diabetes. Dig. Dis. 2018;36:322–324. doi: 10.1159/000487078.
    1. Nieben O.G., Harboe H. Intragastric balloon as an artificial bezoar for treatment of obesity. Lancet. 1982;1:198–199. doi: 10.1016/S0140-6736(82)90762-0.
    1. Velchik M.G., Kramer F.M., Stunkard A.J., Alavi A. Effect of the Garren-Edwards gastric bubble on gastric emptying. J. Nucl. Med. 1989;30:692–696.
    1. Fittipaldi-Fernandez R.J., Zotarelli-Filho I.J., Diestel C.F., Klein M., de Santana M.F., de Lima J.H.F., Bastos F.S.S., Dos Santos N.T. Intragastric Balloon: A Retrospective Evaluation of 5874 Patients on Tolerance, Complications, and Efficacy in Different Degrees of Overweight. Obes. Surg. 2020;30:4892–4898. doi: 10.1007/s11695-020-04985-4.
    1. Lopez-Nava G., Asokkumar R., Rull A., Corbelle F., Beltran L., Bautista I. Bariatric endoscopy procedure type or follow-up: What predicted success at 1 year in 962 obese patients? Endosc. Int. Open. 2019;7:E1691–W1698. doi: 10.1055/a-1007-1769.
    1. Lopez-Nava G., Rubio M.A., Prados S., Pastor G., Cruz M.R., Companioni E., Lopez A. BioEnterics® intragastric balloon (BIB®). Single ambulatory center Spanish experience with 714 consecutive patients treated with one or two consecutive balloons. Obes. Surg. 2011;21:5–9. doi: 10.1007/s11695-010-0093-3.
    1. Kotzampassi K., Grosomanidis V., Papakostas P., Penna S., Eleftheriadis E. 500 intragastric balloons: What happens 5 years thereafter? Obes. Surg. 2012;22:896–903. doi: 10.1007/s11695-012-0607-2.
    1. Suchartlikitwong S., Laoveeravat P., Mingbunjerdsuk T., Vutthikraivit W., Ismail A., Islam S., Islam E. Usefulness of the ReShape intragastric balloon for obesity. Proceedings. 2019;32:192–195. doi: 10.1080/08998280.2018.1559397.
    1. Neylan C.J., Dempsey D.T., Tewksbury C.M., Williams N.N., Dumon K.R. Endoscopic treatments of obesity: A comprehensive review. Surg. Obes. Relat. Dis. 2016;12:1108–1115. doi: 10.1016/j.soard.2016.02.006.
    1. Tate C.M., Geliebter A. Intragastric balloon treatment for obesity: Review of recent studies. Adv. Ther. 2017;34:1859–1875. doi: 10.1007/s12325-017-0562-3.
    1. Vargas E.J., Pesta C.M., Bali A., Ibegbu E., Bazerbachi F., Moore R.L., Kumbhari V., Sharaiha R.Z., Curry T.W., DosSantos G., et al. Single fluid-filled intragastric balloon safe and effective for inducing weight loss in a real-world population. Clin. Gastroenterol. Hepatol. 2018;16:1073–1080.e1. doi: 10.1016/j.cgh.2018.01.046.
    1. Fayad L., Cheskin L.J., Adam A., Badurdeen D.S., Hill C., Agnihotri A., Dunlap M., Simsek C., Khashab M.A., Kalloo A.N., et al. Endoscopic sleeve gastroplasty versus intragastric balloon insertion: Efficacy, durability, and safety. Endoscopy. 2019;51:532–539. doi: 10.1055/a-0852-3441.
    1. Abu Dayyeh B.K., Edmundowicz S.A., Jonnalagadda S., Kumar N., Larsen M., Sullivan S., Thompson C.C., Banerjee S., Forc A.B.E.T., Comm A.T. Endoscopic bariatric therapies. Gastrointest. Endosc. 2015;81:1073–1086. doi: 10.1016/j.gie.2015.02.023.
    1. Herve J., Wahlen C.H., Schaeken A., Dallemagne B., Dewandre J.M., Markiewicz S., Monami B., Weerts J., Jehaes C. What becomes of patients one year after the intragastric balloon has been removed? Obes. Surg. 2005;15:864–870. doi: 10.1381/0960892054222894.
    1. Marinos G., Eliades C., Muthusamy V.R., Greenway F. Weight loss and improved quality of life with a nonsurgical endoscopic treatment for obesity: Clinical results from a 3-and 6-month study. Surg. Obes. Relat. Dis. 2014;10:929–934. doi: 10.1016/j.soard.2014.03.005.
    1. Sauer N., Rosch T., Pezold J., Reining F., Anders M., Groth S., Schachschal G., Mann O., Aberle J. A new endoscopically implantable device (SatiSphere) for treatment of obesity—efficacy, safety, and metabolic effects on glucose, insulin, and GLP-1 levels. Obes. Surg. 2013;23:1727–1733. doi: 10.1007/s11695-013-1005-0.
    1. Barrichello S., Hourneaux de Moura D.T., Hourneaux de Moura E.G., Jirapinyo P., Hoff A.C., Fittipaldi-Fernandez R.J., Baretta G., Felicio Lima J.H., Usuy E.N., de Almeida L.S., et al. Endoscopic sleeve gastroplasty in the management of overweight and obesity: An international multicenter study. Gastrointest. Endosc. 2019;90:770–780. doi: 10.1016/j.gie.2019.06.013.
    1. Lopez-Nava G., Galvao M.P., Bautista-Castano I., Fernandez-Corbelle J.P., Trell M., Lopez N. Endoscopic Sleeve Gastroplasty for Obesity Treatment: Two Years of Experience. Arq. Bras. Cir. Dig. 2017;30:18–20. doi: 10.1590/0102-6720201700010006.
    1. Huberty V., Boskoski I., Bove V., Van Ouytsel P., Costamagna G., Barthet M.A., Deviere J. Endoscopic sutured gastroplasty in addition to lifestyle modification: Short-term efficacy in a controlled randomised trial. Gut. 2020;70:1479–1485. doi: 10.1136/gutjnl-2020-322026.
    1. Lopez-Nava G., Bautista-Castano I., Jimenez A., de Grado T., Fernandez-Corbelle J.P. The Primary Obesity Surgery Endolumenal (POSE) procedure: One-year patient weight loss and safety outcomes. Surg. Obes. Relat. Dis. 2015;11:861–865. doi: 10.1016/j.soard.2014.09.026.
    1. Sullivan S., Swain J.M., Woodman G., Antonetti M., De La Cruz-Muñoz N., Jonnalagadda S.S., Ujiki M., Ikramuddin S., Ponce J., Ryou M., et al. Randomized sham-controlled trial evaluating efficacy and safety of endoscopic gastric plication for primary obesity: The ESSENTIAL trial. J. Obes. 2017;25:294–301. doi: 10.1002/oby.21702.
    1. Lopez-Nava G., Asokkumar R., Turró Arau R., Neto M.G., Dayyeh B.A. Modified primary obesity surgery endoluminal (POSE-2) procedure for the treatment of obesity. VideoGIE. 2020;5:91–93. doi: 10.1016/j.vgie.2019.11.010.
    1. Kumar N. Endoscopic therapy for weight loss: Gastroplasty, duodenal sleeves, intragastric balloons, and aspiration. World J. Gastrointest. Endosc. 2015;7:847–859. doi: 10.4253/wjge.v7.i9.847.
    1. Deviere J., Ojeda Valdes G., Cuevas Herrera L., Closset J., Le Moine O., Eisendrath P., Moreno C., Dugardeyn S., Barea M., de la Torre R., et al. Safety, feasibility and weight loss after transoral gastroplasty: First human multicenter study. Surg. Endosc. 2008;22:589–598. doi: 10.1007/s00464-007-9662-5.
    1. Moreno C., Closset J., Dugardeyn S., Barea M., Mehdi A., Collignon L., Zalcman M., Baurain M., Le Moine O., Deviere J. Transoral gastroplasty is safe, feasible, and induces significant weight loss in morbidly obese patients: Results of the second human pilot study. Endoscopy. 2008;40:406–413. doi: 10.1055/s-2007-995748.
    1. Koehestanie P., de Jonge C., Berends F.J., Janssen I.M., Bouvy N.D., Greve J.W. The effect of the endoscopic duodenal-jejunal bypass liner on obesity and type 2 diabetes mellitus, a multicenter randomized controlled trial. Ann. Surg. 2014;260:984–992. doi: 10.1097/SLA.0000000000000794.
    1. Forner P.M., Ramacciotti T., Farey J.E., Lord R.V. Safety and Effectiveness of an Endoscopically Placed Duodenal-Jejunal Bypass Device (EndoBarrierA (R)): Outcomes in 114 Patients. Obes. Surg. 2017;27:3306–3313. doi: 10.1007/s11695-017-2939-4.
    1. Kaválková P., Mráz M., Trachta P., Kloučková J., Cinkajzlová A., Lacinová Z., Haluzíková D., Beneš M., Vlasáková Z., Burda V., et al. Endocrine effects of duodenal-jejunal exclusion in obese patients with type 2 diabetes mellitus. J. Endocrinol. 2016;231:11–22. doi: 10.1530/JOE-16-0206.
    1. Sandler B.J., Rumbaut R., Swain C.P., Torres G., Morales L., Gonzales L., Schultz S., Talamini M.A., Jacobsen G.R., Horgan S. One-year human experience with a novel endoluminal, endoscopic gastric bypass sleeve for morbid obesity. Surg. Endosc. 2015;29:3298–3303. doi: 10.1007/s00464-015-4081-5.
    1. Norén E., Forssell H. Aspiration therapy for obesity; a safe and effective treatment. BMC Obes. 2016;3:56. doi: 10.1186/s40608-016-0134-0.
    1. Thompson C.C., Abu Dayyeh B.K., Kushnir V., Kushner R.F., Jirapinyo P., Schorr A.B., Aronne L.J., Amaro A., Jaffe D.L., Schulman A.R., et al. Aspiration therapy for the treatment of obesity: 4-year results of a multicenter randomized controlled trial. Surg. Obes. Relat. Dis. 2019;15:1348–1354. doi: 10.1016/j.soard.2019.04.026.
    1. Zhang Y., Du S., Fang L., Yao S., Chen J.D. Retrograde gastric electrical stimulation suppresses calorie intake in obese subjects. J. Obes. 2014;22:1447–1451. doi: 10.1002/oby.20664.
    1. Bohdjalian A., Ludvik B., Guerci B., Bresler L., Renard E., Nocca D., Karnieli E., Assalia A., Prager R., Prager G. Improvement in glycemic control by gastric electrical stimulation (TANTALUS) in overweight subjects with type 2 diabetes. Surg. Endosc. 2009;23:1955–1960. doi: 10.1007/s00464-008-0222-4.
    1. Cha R., Marescaux J., Diana M. Updates on gastric electrical stimulation to treat obesity: Systematic review and future perspectives. World J. Gastrointest. Endosc. 2014;6:419–431. doi: 10.4253/wjge.v6.i9.419.
    1. Gniuli D., Calcagno A., Dalla Libera L., Calvani R., Leccesi L., Caristo M.E., Vettor R., Castagneto M., Ghirlanda G., Mingrone G. High-fat feeding stimulates endocrine, glucose-dependent insulinotropic polypeptide (GIP)-expressing cell hyperplasia in the duodenum of Wistar rats. Diabetologia. 2010;53:2233–2240. doi: 10.1007/s00125-010-1830-9.
    1. Rajagopalan H., Cherrington A.D., Thompson C.C., Kaplan L.M., Rubino F., Mingrone G., Becerra P., Rodriguez P., Vignolo P., Caplan J., et al. Endoscopic duodenal mucosal resurfacing for the treatment of type 2 diabetes: 6-month interim analysis from the first-in-human proof-of-concept study. Diabetes Care. 2016;39:2254–2261. doi: 10.2337/dc16-0383.
    1. van Baar A.C.G., Holleman F., Crenier L., Haidry R., Magee C., Hopkins D., Rodriguez Grunert L., Galvao Neto M., Vignolo P., Hayee B., et al. Endoscopic duodenal mucosal resurfacing for the treatment of type 2 diabetes mellitus: One year results from the first international, open-label, prospective, multicentre study. Gut. 2020;69:295–303. doi: 10.1136/gutjnl-2019-318349.
    1. Hu B., Ye L.S. Endoscopic applications of magnets for the treatment of gastrointestinal diseases. World J. Gastrointest. Endosc. 2019;11:548–560. doi: 10.4253/wjge.v11.i12.548.
    1. Marrache M.K., Itani M.I., Farha J., Fayad L., Sharara S.L., Kalloo A.N., Khashab M.A., Kumbhari V. Endoscopic gastrointestinal anastomosis: A review of established techniques. Gastrointest. Endosc. 2020;93:34–46. doi: 10.1016/j.gie.2020.06.057.
    1. Machytka E., Bužga M., Zonca P., Lautz D.B., Ryou M., Simonson D.C., Thompson C.C. Partial jejunal diversion using an incisionless magnetic anastomosis system: 1-year interim results in patients with obesity and diabetes. Gastrointest. Endosc. 2017;86:904–912. doi: 10.1016/j.gie.2017.07.009.
    1. Bang C.S., Baik G.H., Shin I.S., Kim J.B., Suk K.T., Yoon J.H., Kim Y.S., Kim D.J. Effect of intragastric injection of botulinum toxin A for the treatment of obesity: A meta-analysis and meta-regression. Gastrointest. Endosc. 2015;81:1141–1149.e17. doi: 10.1016/j.gie.2014.12.025.
    1. Buchwald H., Avidor Y., Braunwald E., Jensen M.D., Pories W., Fahrbach K., Schoelles K. Bariatric surgery: A systematic review and meta-analysis. JAMA. 2004;292:1724–1737. doi: 10.1001/jama.292.14.1724.
    1. Maggard M.A., Shugarman L.R., Suttorp M., Maglione M., Sugerman H.J., Livingston E.H., Nguyen N.T., Li Z., Mojica W.A., Hilton L., et al. Meta-analysis: Surgical treatment of obesity. Ann. Intern. Med. 2005;142:547–559. doi: 10.7326/0003-4819-142-7-200504050-00013.
    1. Coupaye M., Puchaux K., Bogard C., Msika S., Jouet P., Clerici C., Larger E., Ledoux S. Nutritional consequences of adjustable gastric banding and gastric bypass: A 1-year prospective study. Obes. Surg. 2009;19:56–65. doi: 10.1007/s11695-008-9571-2.
    1. Kwon Y., Kim H.J., Lo Menzo E., Park S., Szomstein S., Rosenthal R.J. Anemia, iron and vitamin B12 deficiencies after sleeve gastrectomy compared to Roux-en-Y gastric bypass: A meta-analysis. Surg. Obes. Relat. Dis. 2014;10:589–597. doi: 10.1016/j.soard.2013.12.005.
    1. Kaidar-Person O., Person B., Szomstein S., Rosenthal R.J. Nutritional deficiencies in morbidly obese patients: A new form of malnutrition? Part A: Vitamins. Obes. Surg. 2008;18:870–876. doi: 10.1007/s11695-007-9349-y.
    1. Kaidar-Person O., Person B., Szomstein S., Rosenthal R.J. Nutritional deficiencies in morbidly obese patients: A new form of malnutrition? Part B: Minerals. Obes. Surg. 2008;18:1028–1034. doi: 10.1007/s11695-007-9350-5.
    1. Shankar P., Boylan M., Sriram K. Micronutrient deficiencies after bariatric surgery. Nutrition. 2010;26:1031–1037. doi: 10.1016/j.nut.2009.12.003.
    1. Mechanick J.I., Youdim A., Jones D.B., Garvey W.T., Hurley D.L., McMahon M.M., Heinberg L.J., Kushner R., Adams T.D., Shikora S., et al. Clinical practice guidelines for the perioperative nutritional, metabolic, and nonsurgical support of the bariatric surgery patient--2013 update: Cosponsored by American Association of Clinical Endocrinologists, The Obesity Society, and American Society for Metabolic & Bariatric Surgery. Surg. Obes. Relat. Dis. 2013;9:159–191.
    1. Behrns K.E., Smith C.D., Sarr M.G. Prospective evaluation of gastric acid secretion and cobalamin absorption following gastric bypass for clinically severe obesity. Dig. Dis. Sci. 1994;39:315–320. doi: 10.1007/BF02090203.
    1. Aarts E.O., Janssen I.M., Berends F.J. The gastric sleeve: Losing weight as fast as micronutrients? Obes. Surg. 2011;21:207–211. doi: 10.1007/s11695-010-0316-7.
    1. Belfiore A., Cataldi M., Minichini L., Aiello M.L., Trio R., Rossetti G., Guida B. Short-term changes in body composition and response to micronutrient supplementation after laparoscopic sleeve gastrectomy. Obes. Surg. 2015;25:2344–2351. doi: 10.1007/s11695-015-1700-0.
    1. Punchai S., Hanipah Z.N., Meister K.M., Schauer P.R., Brethauer S.A., Aminian A. Neurologic manifestations of vitamin b deficiency after bariatric surgery. Obes. Surg. 2017;27:2079–2082. doi: 10.1007/s11695-017-2607-8.
    1. Lewis C.A., de Jersey S., Hopkins G., Hickman I., Osland E. Does bariatric surgery cause vitamin a, b1, c or e deficiency? A systematic review. Obes. Surg. 2018;28:3640–3657. doi: 10.1007/s11695-018-3392-8.
    1. Koffman B.M., Greenfield L.J., Ali I.I., Pirzada N.A. Neurologic complications after surgery for obesity. Muscle Nerve. 2006;33:166–176. doi: 10.1002/mus.20394.
    1. Damms-Machado A., Friedrich A., Kramer K.M., Stingel K., Meile T., Küper M.A., Königsrainer A., Bischoff S.C. Pre- and postoperative nutritional deficiencies in obese patients undergoing laparoscopic sleeve gastrectomy. Obes. Surg. 2012;22:881–889. doi: 10.1007/s11695-012-0609-0.
    1. Cambi M.P.C., Baretta G.A.P., Spagnol M., Zilio R., Rossoni C. Systematization of nutritional care in endoscopic treatment for obesity. Obes. Surg. 2019;29:1074–1080. doi: 10.1007/s11695-018-3616-y.
    1. Compher C.W., Badellino K.O., Boullata J.I. Vitamin D and the bariatric surgical patient: A review. Obes. Surg. 2008;18:220–224. doi: 10.1007/s11695-007-9289-6.
    1. Wortsman J., Matsuoka L.Y., Chen T.C., Lu Z., Holick M.F. Decreased bioavailability of vitamin D in obesity. Am. J. Clin. Nutr. 2000;72:690–693. doi: 10.1093/ajcn/72.3.690.
    1. Parrott J., Frank L., Rabena R., Craggs-Dino L., Isom K.A., Greiman L. American Society for Metabolic and Bariatric Surgery Integrated Health Nutritional Guidelines for the Surgical Weight Loss Patient 2016 Update: Micronutrients. Surg. Obes. Relat. Dis. 2017;13:727–741. doi: 10.1016/j.soard.2016.12.018.
    1. Tremmel M., Gerdtham U.G., Nilsson P.M., Saha S. Economic burden of obesity: A systematic literature review. Int. J. Env. Res. Public Health. 2017;14:435. doi: 10.3390/ijerph14040435.

Source: PubMed

Sponsors and Collaborators

Medical Conditions

Drug Interventions

3
Subscribe